MCAG SEC Filings - Mountain Crest Acquisition Corp. V- Annual Report, Proxy Statement, Prospectus

Basic Stats

CIK

1859035

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Mountain Crest Acquisition Corp. V

SEC Filings (Chronological Order)

This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.

August 19, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUISI
August 14, 2025	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit
August 7, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 1, 2025 Date of Report (Date of earliest event reported) Mountain Crest Acqu UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 1, 2025 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (C
August 7, 2025	EX-16.1	August 7, 2025 Exhibit 16.1 August 7, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K filed with the U.S. Securities and Exchange Commission on August 7, 2025 of Mountain Crest Acquisition Corp. V (the “Company”) and agree with the statements relating only to UHY LLP contained therein. We have no basis to agree or disagree w
May 22, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUIS
May 15, 2025	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41497 CUSIP NUMBER 27877D104 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi
April 28, 2025	EX-10.1	Promissory Note, dated April 25, 2025 between Mountain Crest Acquisition Corp. V, as Maker and Mountain Crest Global Holdings LLC as Payee Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY
April 28, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 25, 2025 Date of Report (Date of earliest event reported) Mountain Crest Acqu UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 25, 2025 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (C
April 1, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40418 MOUNTAIN CREST ACQUISITION CORP
April 1, 2025	EX-19.1	Insider Trading Policy Exhibit 19.1 Mountain Crest Acquisition Corp. V Insider Trading Policy TABLE OF CONTENTS Page PART I 1 1. Applicability 1 2. General Policy: No Trading or Causing Trading While in Possession of Material Nonpublic Information 2 3. Definitions 2 4. Violations of Insider Trading Rules and Regulations 4 PART II 5 1. Blackout Periods 5 2. Trading Window 6 3. Pre-Clearance of Securities Transactions 6 4
April 1, 2025	EX-4.5	Description of Securities Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2023, the end of the period covered by this Annual Report on Form 10-K, Mountain Crest Acquisition Corp. V (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (
April 1, 2025	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-41062 NOTIFICATION OF LATE FILING CUSIP NUMBER 62404B107 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tra
February 14, 2025	EX-99.(A)	JOINT FILING AGREEMENT EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement is being jointly filed, and all amendments thereto will be jointly filed, by Mountain Crest Global Holdings LLC, as the main and designated filer, on behalf of each of the persons and entities named below that is named as a reporting person in such filing.
December 6, 2024	SC 13G/A	MCAG / Mountain Crest Acquisition Corp. V / Meteora Capital, LLC Passive Investment SC 13G/A 1 meteoramcag113024a3.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* MOUNTAIN CREST ACQUISITION CORP. V (Name of Issuer) Common Stock (Title of Class of Securities) 62404B107 (CUSIP Number) November 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo
November 19, 2024	8-K	Financial Statements and Exhibits, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 14, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation)
November 14, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2024 ☐ TRANSITION REPORT PURSUA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST AC
November 14, 2024	SC 13G/A	MCAG / Mountain Crest Acquisition Corp. V / Meteora Capital, LLC Passive Investment SC 13G/A 1 meteoramcag093024a2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* MOUNTAIN CREST ACQUISITION CORP. V (Name of Issuer) Common Stock (Title of Class of Securities) 62404B107 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate b
November 12, 2024	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 8, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation)
November 12, 2024	EX-3.1	Amendment No. 4 to the Amended and Restated Certificate of Incorporation of Mountain Crest Acquisition Corp., V (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on November 12, 2024) Exhibit 3.1 AMENDMENT NO. 4 TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V November 8, 2024 Mountain Crest Acquisition Corp. V, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Mountain Crest Acquisition Corp. V.” The original certifica
October 31, 2024	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 30, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation)
October 22, 2024	CORRESP	MOUNTAIN CREST ACQUISITION CORP. V 524 Broadway, 11th Floor New York, NY 10012 MOUNTAIN CREST ACQUISITION CORP. V 524 Broadway, 11th Floor New York, NY 10012 October 22, 2024 Via EDGAR Division of Corporation Finance Office of Real Estate a& Construction U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attention: Isabel Rivera Dorrie Yale Re: Mountain Crest Acquisition Corp. V Preliminary Proxy Statement on Schedule 14A Submitted October 21, 2024
October 22, 2024	PRER14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 2 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange PRER14A 1 mountaincrest5prer14a.htm PRER14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 2 to SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriat
October 22, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for the us
October 21, 2024	PRER14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 1 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 1 to SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confi
October 21, 2024	CORRESP	MOUNTAIN CREST ACQUISITION CORP. V 524 Broadway, 11th Floor New York, NY 10012 MOUNTAIN CREST ACQUISITION CORP. V 524 Broadway, 11th Floor New York, NY 10012 October 21, 2024 Via EDGAR Division of Corporation Finance Office of Real Estate a& Construction U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attention: Isabel Rivera Dorrie Yale Re: Mountain Crest Acquisition Corp. V Preliminary Proxy Statement on Schedule 14A Submitted October 10, 2024
October 10, 2024	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for the us
October 4, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUISI
September 18, 2024	8-K	Regulation FD Disclosure, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 13, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation
September 18, 2024	EX-99.1	Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance Exhibit 99.1 Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance New York, New York – September 18, 2024 – Mountain Crest Acquisition Corp. V (the “Company”) (NASDAQ: MCAG), today announced that it received an expected deficiency notification letter from the st
September 13, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUIS
September 12, 2024	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 11, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation
August 30, 2024	EX-99.1	CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT WITH MOUNTAIN CREST V TO BECOME PUBLICLY LISTED Exhibit 99.1 CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT WITH MOUNTAIN CREST V TO BECOME PUBLICLY LISTED NEW YORK, USA and SEOUL, Korea, August 29, 2024 (GLOBE NEWSWIRE) - Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company (“Mountain Crest V”), with its common stock publicly traded on The Nasdaq Stock Market under the trading symbol “MCA
August 30, 2024	EX-2.1	Business Combination Agreement, dated August 29, 2024 by and between Mountain Crest Acquisition Corp. V and CUBEBIO Co., Ltd. Exhibit 2.1 EXECUTION VERSION BUSINESS COMBINATION AGREEMENT by and between MOUNTAIN CREST ACQUISITION CORP. V and CUBEBIO CO. LTD, dated as of August 29, 2024 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 3 1.1 Defined Terms 3 ARTICLE II THE SPAC MERGER AND THE SHARE SWAP 19 2.1 Transactions 19 2.2 Merger Effective Time 20 2.3 Closing 21 ARTICLE III CLOSING TRANSACTIONS 21 3.1 Effect of Merger on
August 30, 2024	EX-2.1	Business Combination Agreement, dated August 29, 2024 by and between Mountain Crest Acquisition Corp. V and CUBEBIO Co., Ltd. Exhibit 2.1 EXECUTION VERSION BUSINESS COMBINATION AGREEMENT by and between MOUNTAIN CREST ACQUISITION CORP. V and CUBEBIO CO. LTD, dated as of August 29, 2024 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 3 1.1 Defined Terms 3 ARTICLE II THE SPAC MERGER AND THE SHARE SWAP 19 2.1 Transactions 19 2.2 Merger Effective Time 20 2.3 Closing 21 ARTICLE III CLOSING TRANSACTIONS 21 3.1 Effect of Merger on
August 30, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fil
August 30, 2024	EX-10.2	Company Support Agreement, dated August 29, 2024 by and between the shareholders listed on Exhibit A thereto, Mountain Crest Acquisition Corp. V and CUBEBIO Co., Ltd. Exhibit 10.2 COMPANY SHAREHOLDER SUPPORT AGREEMENT This COMPANY SHAREHOLDER SUPPORT AGREEMENT, dated as of August 29, 2024 (this “Support Agreement”), is entered into by and among the shareholders listed on Exhibit A hereto (each, a “Company Shareholder”), Mountain Crest Acquisition Corp., V, a Delaware corporation (“SPAC”) and CubeBio Co., Ltd., a corporation (“chusik hoesa”) organized under the
August 30, 2024	EX-10.1	Sponsor Support Agreement, dated August 29, 2024 by and between Mountain Crest Global Holdings LLC, the shareholders listed on Exhibit A thereto and CUBEBIO Co., Ltd. Exhibit 10.1 SPONSOR SUPPORT AGREEMENT This SPONSOR SUPPORT AGREEMENT, dated as of August 29, 2024 (this “Support Agreement”), is entered into by and among Mountain Crest Global Holdings LLC, a Delaware limited liability company (the “Sponsor”), shareholders listed on Exhibit A hereto (each a “Stockholder”) and CubeBio Co., Ltd., a corporation (“chusik hoesa”) organized under the laws of Korea (th
August 30, 2024	EX-10.1	Sponsor Support Agreement, dated August 29, 2024 by and between Mountain Crest Global Holdings LLC, the shareholders listed on Exhibit A thereto and CUBEBIO Co., Ltd. Exhibit 10.1 SPONSOR SUPPORT AGREEMENT This SPONSOR SUPPORT AGREEMENT, dated as of August 29, 2024 (this “Support Agreement”), is entered into by and among Mountain Crest Global Holdings LLC, a Delaware limited liability company (the “Sponsor”), shareholders listed on Exhibit A hereto (each a “Stockholder”) and CubeBio Co., Ltd., a corporation (“chusik hoesa”) organized under the laws of Korea (th
August 30, 2024	EX-99.1	CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT WITH MOUNTAIN CREST V TO BECOME PUBLICLY LISTED Exhibit 99.1 CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT WITH MOUNTAIN CREST V TO BECOME PUBLICLY LISTED NEW YORK, USA and SEOUL, Korea, August 29, 2024 (GLOBE NEWSWIRE) - Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company (“Mountain Crest V”), with its common stock publicly traded on The Nasdaq Stock Market under the trading symbol “MCA
August 30, 2024	425	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fil
August 30, 2024	EX-10.2	Company Support Agreement, dated August 29, 2024 by and between the shareholders listed on Exhibit A thereto, Mountain Crest Acquisition Corp. V and CUBEBIO Co., Ltd. Exhibit 10.2 COMPANY SHAREHOLDER SUPPORT AGREEMENT This COMPANY SHAREHOLDER SUPPORT AGREEMENT, dated as of August 29, 2024 (this “Support Agreement”), is entered into by and among the shareholders listed on Exhibit A hereto (each, a “Company Shareholder”), Mountain Crest Acquisition Corp., V, a Delaware corporation (“SPAC”) and CubeBio Co., Ltd., a corporation (“chusik hoesa”) organized under the
August 26, 2024	EX-99.7	Clawback Policy Exhibit 99.7 MOUNTAIN CREST ACQUISITION CORP. V CLAWBACK POLICY Introduction The Board of Directors (the “Board”) of Mountain Crest Acquisition Corp. V (the “Company”) believes that it is in the best interests of the Company and its stockholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosoph
August 26, 2024	EX-4.5	Description of Securities Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2023, the end of the period covered by this Annual Report on Form 10-K, Mountain Crest Acquisition Corp. V (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (
August 26, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40418 MOUNTAIN CREST ACQUISITION CORP
August 15, 2024	EX-10.1	Promissory Note, dated August 14, 2024 between Mountain Crest Acquisition Corp. V, as Maker and Mountain Crest Global Holdings LLC as Payee Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY
August 15, 2024	8-K	Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 14, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fil
August 14, 2024	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit
July 24, 2024	8-K	Regulation FD Disclosure, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 18, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Co
July 24, 2024	EX-99.1	Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K and Quarterly Report on Form 10-Q Exhibit 99.1 Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K and Quarterly Report on Form 10-Q New York, New York – July 24, 2024 – Mountain Crest Acquisition Corp. V (NASDAQ: MCAG, the “Company”) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staf
June 7, 2024	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 5, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Com
May 15, 2024	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi
May 2, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File Nu
May 2, 2024	EX-99.1	2 Exhibit 99.1 CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V New York, USA and Seoul, Korea – May 2, 2024 – Mountain Crest Acquisition Corp. V, a Delaware corporation (“Mountain Crest V”), that is a Nasdaq-listed (Nasdaq: MCAG) special purpose acquisition company (“SPAC”), and CUBEBIO Co., Ltd., a Korea-based company (“CUBEB
May 2, 2024	425	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V ( SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File Nu
May 2, 2024	EX-99.1	2 Exhibit 99.1 CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V New York, USA and Seoul, Korea – May 2, 2024 – Mountain Crest Acquisition Corp. V, a Delaware corporation (“Mountain Crest V”), that is a Nasdaq-listed (Nasdaq: MCAG) special purpose acquisition company (“SPAC”), and CUBEBIO Co., Ltd., a Korea-based company (“CUBEB
May 1, 2024	EX-10.1	Promissory Note, dated April 30, 2024 between Mountain Crest Acquisition Corp. V, as Maker and Mountain Crest Global Holdings LLC as Payee (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on May 1, 2024) Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY
May 1, 2024	8-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 30, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 30, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File
April 24, 2024	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File
April 24, 2024	EX-10.1	Note Conversion Agreement entered by and between Mountain Crest Acquisition Corp. V and Mountain Crest Global Holdings LLC, dated April 19, 2024 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on April 24, 2024) Exhibit 10.1 NOTE CONVERSION AGREEMENT This NOTE CONVERSION AGREEMENT (this “Agreement”) is made as of April 19, 2024 by and between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Mountain Crest Global Holdings LLC, a Delaware limited liability company and the Company’s sponsor (the “Holder”). R E C I T A L S WHEREAS, the Company issued the Holder a non-interest be
April 3, 2024	8-K	Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 3, 2024 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File
April 3, 2024	EX-10.1	Promissory Note, dated April 3, 2024 between Mountain Crest Acquisition Corp. V, as Maker and Mountain Crest Global Holdings LLC as Payee (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on April 3, 2024) Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY
April 2, 2024	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-41062 NOTIFICATION OF LATE FILING CUSIP NUMBER 62404B107 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tra
February 14, 2024	SC 13G/A	US62404B1070 / Mountain Crest Acquisition Corp. V / Meteora Capital, LLC Passive Investment SC 13G/A 1 meteoramcag123123a1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* MOUNTAIN CREST ACQUISITION CORP. V (Name of Issuer) Common Stock (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo
February 14, 2024	SC 13G/A	US62404B1070 / Mountain Crest Acquisition Corp. V / Mountain Crest Global Holdings LLC - SC 13G/A Passive Investment SC 13G/A 1 mountaincrestsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 1)* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 per Share (T
February 5, 2024	SC 13G/A	US62404B1070 / Mountain Crest Acquisition Corp. V / Owl Creek Asset Management, L.P. - MOUNTAIN CREST ACQUISITION CORP. V Passive Investment SC 13G/A 1 p24-0522sc13ga.htm MOUNTAIN CREST ACQUISITION CORP. V SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of thi
December 19, 2023	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 13, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
November 21, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2023 ☐ TRANSITION REPORT PURSUA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST AC
November 14, 2023	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr
November 13, 2023	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 9, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fi
November 1, 2023	EX-10.1	Promissory Note, dated October 30, 2023 between Mountain Crest Acquisition Corp. V, as Maker and Mountain Crest Global Holdings LLC as Payee Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY
November 1, 2023	8-K	Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 30, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fi
October 26, 2023	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 23, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fi
October 26, 2023	EX-99.1	Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market Exhibit 99.1 Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) - Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market (“Nasdaq”) to transfer the listing of its securities from the Nasdaq Global Market to the Nasdaq Capital Market.
September 19, 2023	EX-10.3	Vendor Liability Conversion Agreement entered by and between Mountain Crest Acquisition Corp. V and Vendor No. 3, dated September 13, 2023 Exhibit 10.3 [Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain term to this exhibit have been omitted as they are both not material and of the type that the registrant treats as private or confidential. A copy of unredacted copy of the exhibit will be furnished supplementally to the SEC upon request.] LIABILITY CONVERSION AGREEMENT This LIABILITY CONVERSION AGREEMENT (this “Agreement”) i
September 19, 2023	EX-10.2	Vendor Liability Conversion Agreement entered by and between Mountain Crest Acquisition Corp. V and Vendor No. 2, dated September 13, 2023 Exhibit 10.2 [Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain term to this exhibit have been omitted as they are both not material and of the type that the registrant treats as private or confidential. A copy of unredacted copy of the exhibit will be furnished supplementally to the SEC upon request.] LIABILITY CONVERSION AGREEMENT This LIABILITY CONVERSION AGREEMENT (this “Agreement”) i
September 19, 2023	EX-10.5	Note Conversion Agreement entered by and between Mountain Crest Acquisition Corp. V and Mountain Crest Global Holdings LLC, dated September 13, 2023 Exhibit 10.5 NOTE CONVERSION AGREEMENT This NOTE CONVERSION AGREEMENT (this “Agreement”) is made as of September 13, 2023 by and between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Mountain Crest Global Holdings, LLC, a Delaware limited liability company (the “Holder”). R E C I T A L S WHEREAS, the Company issued the Holder a non-interest bearing promissory note
September 19, 2023	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 13, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission
September 19, 2023	EX-10.1	Vendor Liability Conversion Agreement entered by and between Mountain Crest Acquisition Corp. V and Vendor No. 1, dated September 13, 2023 Exhibit 10.1 [Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain term to this exhibit have been omitted as they are both not material and of the type that the registrant treats as private or confidential. A copy of unredacted copy of the exhibit will be furnished supplementally to the SEC upon request.] LIABILITY CONVERSION AGREEMENT This LIABILITY CONVERSION AGREEMENT (this “Agreement”) i
September 19, 2023	EX-10.4	Vendor Liability Conversion Agreement entered by and between Mountain Crest Acquisition Corp. V and Vendor No. 4, dated September 13, 2023 Exhibit 10.4 [Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain term to this exhibit have been omitted as they are both not material and of the type that the registrant treats as private or confidential. A copy of unredacted copy of the exhibit will be furnished supplementally to the SEC upon request.] LIABILITY CONVERSION AGREEMENT This LIABILITY CONVERSION AGREEMENT (this “Agreement”) i
August 22, 2023	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders, Other Events SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 21, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission Fil
August 21, 2023	EX-3.1	Amendment No. 3 to the Amended and Restated Certificate of Incorporation of Mountain Crest Acquisition Corp., V dated August 21, 2023 (incorporated herein by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q filed with the SEC on August 21, 2023) Exhibit 3.1 Charter Amendment AMENDMENT NO. 3 TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V August 21, 2023 Mountain Crest Acquisition Corp. V, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Mountain Crest Acquisition Corp. V.” The o
August 21, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUISI
August 21, 2023	EX-10.1	Amendment to Promissory Note between Mountain Crest Acquisition Corp. V and Mountain Crest Global Holdings LLC dated May 16, 2023 Exhibit 10.1 AMENDMENT TO PROMISSORY NOTE THIS AMENDMENT TO PROMISSORY NOTE (this “Agreement”), dated as of May 16, 2023, by and between Mountain Crest Acquisition Corp. V, a Delaware corporation and blank check company (the “Maker”), and Mountain Crest Global Holdings LLC (the “Payee”). WHEREAS, Maker executed and delivered a Promissory Note dated as of February 15, 2023 (the “Note”) for the bene
August 14, 2023	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-41062 CUSIP NUMBER 62404B107 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit
August 8, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for the us
July 21, 2023	PRER14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confid
July 21, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 18, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acqui UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 18, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co
June 30, 2023	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for the us
June 30, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 27, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acqui UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 27, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co
June 20, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acqui UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co
June 20, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acqui UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co
June 20, 2023	8-K	Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co
June 14, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquis Filed by AUM Biosciences Limited. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Mountain Crest Acquisition Corp. V Commission File No.: 001-41062 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities
June 14, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquis UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com
June 14, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquis UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com
June 12, 2023	SC 13G	US62404B1070 / Mountain Crest Acquisition Corp. V / Meteora Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
May 24, 2023	DEFR14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi
May 22, 2023	DEFM14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin
May 22, 2023	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 18, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com
May 15, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUIS
May 12, 2023	EX-3.1	Second Amendment to the Amended and Restated Certificate of Incorporation of Mountain Crest Acquisition Corp., V dated May 12, 2023 Exhibit 3.1 SECOND AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V May 12, 2023 Mountain Crest Acquisition Corp. V, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Mountain Crest Acquisition Corp. V.” The original certificate
May 12, 2023	425	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 12, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 12, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File N
May 12, 2023	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 12, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation) (Commission File N
May 12, 2023	EX-3.1	Second Amendment to the Amended and Restated Certificate of Incorporation of Mountain Crest Acquisition Corp., V dated May 12, 2023 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on May 12, 2023) Exhibit 3.1 SECOND AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V May 12, 2023 Mountain Crest Acquisition Corp. V, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Mountain Crest Acquisition Corp. V.” The original certificate
May 11, 2023	425	INVESTOR PRESENTATION May 2023 (Corrected Version) This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the Filed by AUM Biosciences Limited. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Mountain Crest Acquisition Corp. V Commission File No.: 001-41062 INVESTOR PRESENTATION May 2023 (Corrected Version) This presentation is provided for informational purposes only and has been prepared to assist i
May 11, 2023	EX-99.1	INVESTOR PRESENTATION May 2023 (Corrected Version) This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the Exhibit 99.1 INVESTOR PRESENTATION May 2023 (Corrected Version) This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the “proposed business combination”) among (i) AUM Bioscienc es Limited (“Holdco”), (ii) AUM Biosciences Subsidiary Pte. Ltd., (iii) AUM Bios
May 11, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquis UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com
May 10, 2023	EX-99.1	INVESTOR PRESENTATION May 2023 This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the “proposed business c Exhibit 99.1 INVESTOR PRESENTATION May 2023 This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the “proposed business combination”) among (i) AUM Bioscienc es Limited (“Holdco”), (ii) AUM Biosciences Subsidiary Pte. Ltd., (iii) AUM Biosciences Delaware Mer
May 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 10, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquis UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 10, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Com
May 10, 2023	425	INVESTOR PRESENTATION May 2023 This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the “proposed business c Filed by AUM Biosciences Limited. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Mountain Crest Acquisition Corp. V Commission File No.: 001-41062 INVESTOR PRESENTATION May 2023 This presentation is provided for informational purposes only and has been prepared to assist interested parties in
April 27, 2023	425	AUM Biosciences to Participate in Inaugural EF Hutton Global Conference Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences to Participate in Inaugural EF Hutton Global Conference Singapore and Bethesda, MD, April 26, 2023 - AUM Biosciences Pte.
April 26, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for the us
April 26, 2023	CORRESP	345 Park Avenue 345 Park Avenue New York, NY 10154-1895 Direct Main Fax 212.407.4000 212.407.4000 212.407.4990 April 26, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Attn: Isabel Rivera Re: Mountain Crest Acquisition Corp. V Preliminary Proxy Statement on Form PRE14A Filed April 14, 2023 File No
April 25, 2023	CORRESP	345 Park Avenue 345 Park Avenue New York, NY 10154-1895 Direct Main Fax 212.407.4000 212.407.4000 212.407.4990 April 25, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Attn: Isabel Rivera Re: Mountain Crest Acquisition Corp. V Preliminary Proxy Statement on Form PRE14A Filed April 14, 2023 File No
April 19, 2023	EX-2.1	Amendment No. 3 to Business Combination Agreement, dated as of April 19, 2023, by and among Mountain Crest Acquisition Corp. V, AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd., and AUM Biosciences Delaware Merger Sub, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on April 19, 2023) Exhibit 2.1 AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT (this “Amendment No. 3”) is made as of April 19, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private compa
April 19, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acqu UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (C
April 19, 2023	EX-2.1	Amendment No. 3 to Business Combination Agreement, dated as of April 19, 2023, by and among Mountain Crest Acquisition Corp. V, AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd., and AUM Biosciences Delaware Merger Sub, Inc. Exhibit 2.1 AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT NO. 3 TO BUSINESS COMBINATION AGREEMENT (this “Amendment No. 3”) is made as of April 19, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private compa
April 19, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 19, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (C
April 14, 2023	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for the us
April 7, 2023	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 3, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (Co
March 31, 2023	EX-10.2	Promissory Note issued by UHY Advisors/UHY LLP to Mountain Crest Acquisition Corp. V on March 31, 2023 (incorporated by reference to Exhibit 10.2 to the Annual Report on Form 10-K filed with the Securities & Exchange Commission on March 31, 2023) Exhibit 10.2 PROMISSORY NOTE Principal Amount: $108,001.90 Date: March 31, 2023 New York, New York On demand, for valuable consideration given to Mountain Crest Acquisition Corp. V (hereinafter “Maker”), Maker does hereby promise to pay to UHY Advisors/UHY LLP, (hereinafter “Holder”), at 1185 Avenue of the Americas, 38th Floor, New York, NY 10036, the principal sum of One Hundred Eight Thousand On
March 31, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40418 MOUNTAIN CREST ACQUISITION CORP
March 31, 2023	EX-4.5	Description of Securities Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2022, the end of the period covered by this Annual Report on Form 10-K, Mountain Crest Acquisition Corp. V (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (
March 30, 2023	EX-2.1	Amendment No. 2 to Business Combination Agreement, dated as of March 30, 2023, by and among Mountain Crest Acquisition Corp. V, AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd., and AUM Biosciences Delaware Merger Sub, Inc. Exhibit 2.1 AMENDMENT #2 TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT #2 TO BUSINESS COMBINATION AGREEMENT (this “Amendment #2”) is made as of March 30, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limite
March 30, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acqu UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (C
March 30, 2023	EX-2.1	Amendment No. 2 to Business Combination Agreement, dated as of March 30, 2023, by and among Mountain Crest Acquisition Corp. V, AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd., and AUM Biosciences Delaware Merger Sub, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on March 30, 2023) Exhibit 2.1 AMENDMENT #2 TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT #2 TO BUSINESS COMBINATION AGREEMENT (this “Amendment #2”) is made as of March 30, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limite
March 30, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acqu UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation) (C
February 16, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 15, 2023 Date of Report (Date of earliest event reported) Mountain Crest A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 15, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
February 16, 2023	8-K	Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 15, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
February 16, 2023	EX-10.1	Promissory Note issued by Mountain Crest Acquisition Corp. V to Mountain Crest Global Holdings LLC on February 15, 2023 Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY
February 16, 2023	EX-10.1	Promissory Note issued by Mountain Crest Acquisition Corp. V to Mountain Crest Global Holdings LLC on February 15, 2023 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on February 16, 2023) EX-10.1 2 mountaincrest5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACT
February 14, 2023	SC 13G/A	US62404B1070 / Mountain Crest Acquisition Corp. V / Saba Capital Management, L.P. - FORM SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate
February 14, 2023	SC 13G/A	US62404B1070 / Mountain Crest Acquisition Corp. V / Karpus Management, Inc. - KARPUS INVESTMENT MGT / MOUNTAIN CREST ACQUISITION CORP. V - SCHEDULE 13G/A(#1E) Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * Mountain Crest Acquisition Corp. V (Name of Issuer) Common (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to whic
February 13, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 10, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
February 13, 2023	SC 13G/A	US62404B1070 / Mountain Crest Acquisition Corp. V / Beryl Capital Management LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t
February 13, 2023	EX-2.1	Amendment to Business Combination Agreement, dated as of February 10, 2023, by and among Mountain Crest Acquisition Corp. V, AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd., and AUM Biosciences Delaware Merger Sub, Inc. Exhibit 2.1 AMENDMENT TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT TO BUSINESS COMBINATION AGREEMENT (this “Amendment”) is made as of February 10, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limited by s
February 13, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 10, 2023 Date of Report (Date of earliest event reported) Mountain Crest A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 10, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
February 13, 2023	SC 13G/A	US62404B1070 / Mountain Crest Acquisition Corp. V / PERISCOPE CAPITAL INC. - SC 13G/A Passive Investment SC 13G/A 1 d400625dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mountain Crest Acquisition Corp V (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Sta
February 13, 2023	EX-2.1	Amendment to Business Combination Agreement, dated as of February 10, 2023, by and among Mountain Crest Acquisition Corp. V, AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd., and AUM Biosciences Delaware Merger Sub, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on February 13, 2023) Exhibit 2.1 AMENDMENT TO BUSINESS COMBINATION AGREEMENT THIS AMENDMENT TO BUSINESS COMBINATION AGREEMENT (this “Amendment”) is made as of February 10, 2023 (the “Amendment Date”) by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”), AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limited by s
February 9, 2023	SC 13G	US62404B1070 / Mountain Crest Acquisition Corp. V / Owl Creek Asset Management, L.P. - MOUNTAIN CREST ACQUISITION CORP. V Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan
January 30, 2023	EX-2.1	Joinder Agreement, dated as of January 27, 2023, by and between Mountain Crest Acquisition Corp. V, AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd. and AUM Biosciences Delaware Merger Sub, Inc. Exhibit 2.1 JOINDER AGREEMENT This JOINDER AGREEMENT, dated as of January 27, 2023 (this “Joinder Agreement”), to the Business Combination Agreement (as the same may be amended, restated, supplemented or modified from time to time in accordance with the terms hereof, the “Business Combination Agreement”), dated as of October 19, 2022, by and between Mountain Crest Acquisition Corp. V, a Delaware c
January 30, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 27, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
January 30, 2023	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 27, 2023 Date of Report (Date of earliest event reported) Mountain Crest Ac 425 1 mountaincrestv425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 27, 2023 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other
January 30, 2023	EX-2.1	Joinder Agreement, dated as of January 27, 2023, by and between Mountain Crest Acquisition Corp. V, AUM Biosciences Pte. Ltd., AUM Biosciences Limited, AUM Biosciences Subsidiary Pte. Ltd. and AUM Biosciences Delaware Merger Sub, Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on January 30, 2023) EX-2.1 2 mountaincrestvex2-1.htm EXHIBIT 2.1 Exhibit 2.1 JOINDER AGREEMENT This JOINDER AGREEMENT, dated as of January 27, 2023 (this “Joinder Agreement”), to the Business Combination Agreement (as the same may be amended, restated, supplemented or modified from time to time in accordance with the terms hereof, the “Business Combination Agreement”), dated as of October 19, 2022, by and between Mou
January 5, 2023	425	AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma AUM302 is potentially elig
December 21, 2022	EX-3.1	Amendment to the Amended and Restated Certificate of Incorporation of Mountain Crest Acquisition Corp., V dated December 20, 2022 Exhibit 3.1 2 3
December 21, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
December 21, 2022	EX-10.1	Amendment to the Investment Management Trust Agreement, dated as of November 12, 2021, between Mountain Crest Acquisition Corp. V and Continental Stock Transfer & Trust Company dated December 20, 2022 Exhibit 10.1 AMENDMENT TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT This Amendment No. 1 (this ?Amendment?), dated as of December 20, 2022, to the Investment Management Trust Agreement (as defined below) is made by and between Mountain Crest Acquisition Corp. V (the ?Company?) and Continental Stock Transfer & Trust Company, as trustee (?Trustee?). All terms used but not defined herein shall have t
December 21, 2022	EX-10.1	Amendment to the Investment Management Trust Agreement, dated as of November 12, 2021, between Mountain Crest Acquisition Corp. V and Continental Stock Transfer & Trust Company dated December 20, 2022 EX-10.1 3 mountaincrest5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 AMENDMENT TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT This Amendment No. 1 (this “Amendment”), dated as of December 20, 2022, to the Investment Management Trust Agreement (as defined below) is made by and between Mountain Crest Acquisition Corp. V (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”). Al
December 21, 2022	EX-3.1	Amendment to the Amended and Restated Certificate of Incorporation of Mountain Crest Acquisition Corp., V dated December 20, 2022 Exhibit 3.1 2 3
December 21, 2022	8-K	Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-40418 85-2412613 (State or other jurisdiction of incorporation)
December 19, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 19, 2022 Date of Report (Date of earliest event reported) Mountain Crest A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 19, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
December 19, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 19, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
December 6, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEF 14A 1 mountaincrest5def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary
November 30, 2022	425	AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma AUM302 has potential to be the first m
November 25, 2022	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for the us
November 16, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 16, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
November 16, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 16, 2022 Date of Report (Date of earliest event reported) Mountain Crest A 425 1 mountaincrest5425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 16, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or othe
November 16, 2022	EX-99.1	INVESTOR PRESENTATION NOVEMBER 2022 Exhibit 99.1 INVESTOR PRESENTATION NOVEMBER 2022 This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the ? proposed business combination ? ) among (i) AUM Biosciences Limited ( ? Holdco ? ), (ii) AUM Biosciences Subsidiary Pte. Ltd., (iii) a to be formed De
November 16, 2022	EX-99.1	INVESTOR PRESENTATION NOVEMBER 2022 Exhibit 99.1 INVESTOR PRESENTATION NOVEMBER 2022 This presentation is provided for informational purposes only and has been prepared to assist interested parties in making th eir own evaluation with respect to a potential business combination (the ? proposed business combination ? ) among (i) AUM Biosciences Limited ( ? Holdco ? ), (ii) AUM Biosciences Subsidiary Pte. Ltd., (iii) a to be formed De
November 15, 2022	425	AUM Biosciences Receives Human Research Ethics Committee Approval to Commence Phase II Clinical Trial of AUM001 for Treatment of Metastatic Colorectal Cancer in Australia 425 1 mountaincrestv425.htm 425 Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences Receives Human Research Ethics Committee Approval to Commence Phase II Clinical Trial of
November 7, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2022 ☐ TRANSITION REPORT PURSUA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST AC
November 4, 2022	425	AUM Biosciences to Participate in BioCentury-BayHelix East-West BioPharma Summit Filed by MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Commission File No. 001-41062 Subject Company: MOUNTAIN CREST ACQUISITION CORP. V AUM Biosciences to Participate in BioCentury-BayHelix East-West BioPharma Summit SINGAPORE and BETHESDA, Md., Nov. 04, 2022 (GLOBE NEWSWI
October 20, 2022	EX-10.4	Form of Amended and Restated Registration Rights Agreement. Exhibit 10.4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [ ], 2022, is made and entered into by and among [ ], a Cayman Islands exempted company (the “Company”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration number 201810204D (“AUM”),
October 20, 2022	EX-10.2	Sponsor Support Agreement, dated as of October 19, 2022, by and among MCAG, Aum Biosciences Pte. Ltd. and certain holders of MCAG’s common stock. (incorporated by reference to Exhibit 10.2 to Form 8-K, filed by MCAG on October 20, 2022) Exhibit 10.2 Execution Version SPAC STOCKHOLDER SUPPORT AGREEMENT This SPAC STOCKHOLDER SUPPORT AGREEMENT, dated as of October 19, 2022 (this ?Agreement?), is entered into by and among the stockholders listed on Exhibit A hereto (each, a ?Stockholder?), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration number 201810204D (the ?Compan
October 20, 2022	EX-10.2	Sponsor Support Agreement, dated as of October 19, 2022, by and among SPAC, the Company and certain holders of SPAC’s common stock. EX-10.2 4 mountaincrest5ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 Execution Version SPAC STOCKHOLDER SUPPORT AGREEMENT This SPAC STOCKHOLDER SUPPORT AGREEMENT, dated as of October 19, 2022 (this “Agreement”), is entered into by and among the stockholders listed on Exhibit A hereto (each, a “Stockholder”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with com
October 20, 2022	EX-2.1	Business Combination Agreement, dated as of October 19, 2022, by and between SPAC and the Company. EX-2.1 2 mountaincrest5ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 Execution Version BUSINESS COMBINATION AGREEMENT by and between MOUNTAIN CREST ACQUISITION CORP. V, and AUM BIOSCIENCES PTE. LTD. dated as of October 19, 2022 *Certain exhibits and the schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of any om
October 20, 2022	EX-99.1	AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V Exhibit 99.1 AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V ? The transaction reflects a pre-money equity value of $400 million for AUM Biosciences ? Transaction is expected to provide $69 million of gross proceeds (assuming no redemptions by Mountain Crest sto
October 20, 2022	EX-10.3	Form of Lock-up Agreement. EX-10.3 5 mountaincrest5ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is dated as of , 2022, by and among the undersigned (the “Holder”), [ ], a Cayman Islands exempted company (“Holdco”) and Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”). Capitalized terms used and not otherwise defined herein shall have the meanings given su
October 20, 2022	EX-10.1	Shareholder Support Agreement, dated as of October 19, 2022, by and among SPAC, the Company and certain shareholders of the Company. EX-10.1 3 mountaincrest5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version COMPANY SHAREHOLDER SUPPORT AGREEMENT This COMPANY SHAREHOLDER SUPPORT AGREEMENT, dated as of October 19, 2022 (this “Support Agreement”), is entered into by and among the shareholders listed on Exhibit A hereto (each, a “Shareholder”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singa
October 20, 2022	EX-10.1	Shareholder Support Agreement, dated as of October 19, 2022, by and among SPAC, the Company and certain shareholders of the Company. EX-10.1 3 mountaincrest5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version COMPANY SHAREHOLDER SUPPORT AGREEMENT This COMPANY SHAREHOLDER SUPPORT AGREEMENT, dated as of October 19, 2022 (this “Support Agreement”), is entered into by and among the shareholders listed on Exhibit A hereto (each, a “Shareholder”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singa
October 20, 2022	EX-10.4	Form of Amended and Restated Registration Rights Agreement. EX-10.4 6 mountaincrest5ex10-4.htm EXHIBIT 10.4 Exhibit 10.4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [ ], 2022, is made and entered into by and among [ ], a Cayman Islands exempted company (the “Company”), AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with
October 20, 2022	EX-10.3	Form of Lock-up Agreement. EX-10.3 5 mountaincrest5ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is dated as of , 2022, by and among the undersigned (the “Holder”), [ ], a Cayman Islands exempted company (“Holdco”) and Mountain Crest Acquisition Corp. V, a Delaware corporation (“SPAC”). Capitalized terms used and not otherwise defined herein shall have the meanings given su
October 20, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Ac 425 1 mountaincrest5425.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other
October 20, 2022	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 20, 2022 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
October 20, 2022	EX-2.1	Business Combination Agreement, dated as of October 19, 2022, by and between SPAC and the Company. Exhibit 2.1 Execution Version BUSINESS COMBINATION AGREEMENT by and between MOUNTAIN CREST ACQUISITION CORP. V, and AUM BIOSCIENCES PTE. LTD. dated as of October 19, 2022 *Certain exhibits and the schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its
October 20, 2022	EX-99.1	AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V EX-99.1 7 mountaincrest5ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V · The transaction reflects a pre-money equity value of $400 million for AUM Biosciences · Transaction is expected to provide $69 million of gross proceed
August 12, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUISI
May 13, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41062 MOUNTAIN CREST ACQUIS
March 31, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40418 MOUNTAIN CREST ACQUISITION CORP
March 31, 2022	EX-4.5	Description of Securities EX-4.5 2 mountaincrestex4-5.htm EXHIBIT 4.5 Exhibit 4.5 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2021, the end of the period covered by this Annual Report on Form 10-K, Mountain Crest Acquisition Corp. V (the “Company,” “we,” “us,” or “our”) had three classes of securities registered under Section 12 of the S
February 14, 2022	SC 13G	MCAG / Mountain Crest Acquisition Corp V / Mountain Crest Global Holdings LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ?240.13d-2 Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 per Share (Title of Class of Securities) 62404B 107 (CUSIP
February 14, 2022	SC 13G	MCAG / Mountain Crest Acquisition Corp V / PERISCOPE CAPITAL INC. - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp V (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to des
February 14, 2022	SC 13G	MCAG / Mountain Crest Acquisition Corp V / Karpus Management, Inc. - KARPUS INVESTMENT MGT / MOUNTAIN CREST ACQUISITION CORP. V - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.     ) * Mountain Crest Acquisition Corp. V (Name of Issuer) Common (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to w
February 11, 2022	SC 13G/A	MCAG / Mountain Crest Acquisition Corp V / Beryl Capital Management LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t
February 7, 2022	SC 13G/A	MCAG / Mountain Crest Acquisition Corp V / MMCAP International Inc. SPC - FORM SC 13G/A Passive Investment SC 13G/A 1 formsc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A AMENDMENT NO. 1 INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 31, 2021 (Da
December 23, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41062 MOUNTAIN CRE
December 17, 2021	SC 13G	Saba Capital Management, L.P. - FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 62404B107 (CUSIP Number) December 7, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the
November 30, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 30, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
November 30, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 30, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
November 24, 2021	EX-99.1	Mountain Crest Acquisition Corp. V BALANCE SHEET Exhibit 99.1 Mountain Crest Acquisition Corp. V BALANCE SHEET November 16, Pro Forma Adjustments As Adjusted 2021 (unaudited) (unaudited) ASSETS CURRENT ASSETS Cash $ 610,839 $ - $ 610,839 Prepaid expenses 29,200 - 29,200 Cash held in Trust 60,000,000 9,000,000 (a) 69,000,000 180,000 (b) (180,000 )(c) Total current assets 60,640,039 9,000,000 69,640,039 TOTAL ASSETS $ 60,640,039 $ 9,000,000 $ 69,6
November 24, 2021	8-K	Other Events, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 18, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
November 22, 2021	8-K	Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 16, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
November 22, 2021	EX-99.1	MOUNTAIN CREST ACQUISITION CORP. V INDEX TO FINANCIAL STATEMENT Exhibit 99.1 MOUNTAIN CREST ACQUISITION CORP. V INDEX TO FINANCIAL STATEMENT Page Financial Statement: Report of Independent Registered Public Accounting Firm F-1 Balance Sheet as of November 16, 2021 F-2 Notes to Financial Statement F-3 Table of Contents REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Mountain Crest Acquisition Corp. V Opinion
November 19, 2021	SC 13G	Beryl Capital Management LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 62404B2061 (CUSIP Number) November 12, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t
November 19, 2021	SC 13G	Space Summit Capital LLC - SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Mountain Crest Acquisition Corp. V (Name of Issuer) Units (Title of Class of Securities) 62404B206 (CUSIP Number) November 12, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t
November 18, 2021	EX-10.4	Registration Rights Agreement, dated November 12, 2021, by and between the Company and Initial Stockholders. Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [●] day of November, 2021, by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”) and the undersigned parties listed under Investors on the signature page hereto (each, an “Investor” and collectively, the “Investors”). WHEREAS, the Investors an
November 18, 2021	EX-4.1	Rights Agreement, dated November 12, 2021, by and between Continental Stock Transfer & Trust Company and the Company. Exhibit 4.1 RIGHTS AGREEMENT This Rights Agreement (this “Agreement”) is made as of November 12, 2021 between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State Street, New York, New York 10004 (the “Right Agent”). WHEREAS, the Company has received a firm commitment from Chardan
November 18, 2021	EX-1.1	Underwriting Agreement, dated November 12, 2021, by and between the Company and Chardan Capital Markets, LLC. Exhibit 1.1 6,000,000 Units Mountain Crest Acquisition Corp. V UNDERWRITING AGREEMENT November 12, 2021 Chardan Capital Markets, LLC 17 State Street, 21st Floor New York, New York 10004 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, Mountain Crest Acquisition Corp. V, a Delaware corporation (“Company”), hereby confirms its agreement with Cha
November 18, 2021	EX-10.3	Stock Escrow Agreement, dated November 12, 2021, among the Company, Continental Stock Transfer & Trust Company and the Initial Stockholders. Exhibit 10.3 STOCK ESCROW AGREEMENT This STOCK ESCROW AGREEMENT, dated as of November 12, 2021 (?Agreement?), by and among MOUNTAIN CREST ACQUISITION CORP. V, a Delaware corporation (?Company?), and the initial shareholders listed on the signature pages hereto (collectively, the ?Initial Shareholders?) CONTINENTAL STOCK TRANSFER & TRUST COMPANY, a New York corporation (?Escrow Agent?). WHEREAS, th
November 18, 2021	SC 13G	MMCAP International Inc. SPC - NONE Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Mountain Crest Acquisition Corp. V (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 62404B206 (CUSIP Number) November 16, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box
November 18, 2021	EX-10.2	Investment Management Trust Agreement, dated November 12, 2021, by and between Continental Stock Transfer & Trust Company and the Company. Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made as of November [●], 2021 by and between Mountain Crest Acquisition Corp. V (the “Company”) and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Form S-1, No. 333-260124 (“Registration Statement”)
November 18, 2021	EX-3.1	Amended and Restated Certificate of Incorporation. Exhibit 3.1
November 18, 2021	EX-10.6	Subscription Agreement, dated November 12, 2021, by and between the Company and Mountain Crest Global Holdings LLC. Exhibit 10.6 November [?], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: Mountain Crest Acquisition Corp. V (the ?Company?), a blank check company formed for the purpose of acquiring one or more businesses or entities (a ?Business Combination?), intends to register its securities under the Securities Act of 1933, as amended (?Secu
November 18, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 12, 2021 Date of Report (Date of earliest event reported) Mountain Crest Acquisition Corp. V (Exact Name of Registrant as Specified in its Charter) Delaware 001-41062 86-1768041 (State or other jurisdiction of incorporation)
November 18, 2021	EX-10.5	Indemnity Agreement, dated November 12, 2021, by and among the Company and the directors and officers of the Registrant Exhibit 10.5 FORM OF INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of November [?], 2021, by and between Mountain Crest Acquisition Corp. V, a Delaware corporation (the ?Company?), and the undersigned directors and officers of the Company (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly held corporations as directo
November 18, 2021	EX-10.7	Administrative Service Agreement, dated November 12, 2021, by and between the Company and Mountain Crest Global Holdings LLC. Exhibit 10.7 MOUNTAIN CREST ACQUISITION CORP. V 311 West 43rd Street, 12th Floor New York, NY 10036 [], 2021 Mountain Crest Global Holdings LLC 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the effective date (the ?Effective Date?) of the registration statement (the ?Registration Statement?) for the initial publ
November 18, 2021	EX-10.1	Letter Agreement, dated November 12, 2021, among the Company and the Company’s officers, directors and Initial Stockholders. Exhibit 10.1 November [?], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Chardan Capital Markets, LLC 17 State Street, Suite 1600 New York, NY 10004 Re: Initial Public Offering Gentlemen: This letter is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and between Mountain Crest Acquisit
November 15, 2021	424B4	$60,000,000 Mountain Crest Acquisition Corp. V 6,000,000 Units Prospectus Filed Pursuant to Rule 424(b)(4) Registration No. 333-260124 $60,000,000 Mountain Crest Acquisition Corp. V 6,000,000 Units Mountain Crest Acquisition Corp. V is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although there is no restriction
November 12, 2021	8-A12B	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Mountain Crest Acquisition Corp. V (Exact Name UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Mountain Crest Acquisition Corp.
November 9, 2021	EX-10.4	Form of Registration Rights Agreement by and between the Registrant and Initial Stockholders. Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [●] day of [●], 2021, by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”) and the undersigned parties listed under Investors on the signature page hereto (each, an “Investor” and collectively, the “Investors”). WHEREAS, the Investors and the
November 9, 2021	S-1/A	As filed with the Securities and Exchange Commission on November 8, 2021 As filed with the Securities and Exchange Commission on November 8, 2021 Registration No.
November 9, 2021	EX-10.7	Form of Subscription Agreement between Registrant and Mountain Crest Global Holdings LLC. Exhibit 10.7 [●], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: Mountain Crest Acquisition Corp. V (the “Company”), a blank check company formed for the purpose of acquiring one or more businesses or entities (a “Business Combination”), intends to register its securities under the Securities Act of 1933, as amended (“Securities Ac
November 9, 2021	EX-10.3	Form of Stock Escrow Agreement among the Registrant, Continental Stock Transfer & Trust Company, and the Initial Stockholders. Exhibit 10.3 STOCK ESCROW AGREEMENT This STOCK ESCROW AGREEMENT, dated as of , 2021 (?Agreement?), by and among MOUNTAIN CREST ACQUISITION CORP. V, a Delaware corporation (?Company?), and the initial shareholders listed on the signature pages hereto (collectively, the ?Initial Shareholders?) CONTINENTAL STOCK TRANSFER & TRUST COMPANY, a New York corporation (?Escrow Agent?). WHEREAS, the Company h
November 9, 2021	EX-1.1	Form of Underwriting Agreement. Exhibit 1.1 6,000,000 Units Mountain Crest Acquisition Corp. V UNDERWRITING AGREEMENT , 2021 Chardan Capital Markets, LLC  17 State Street, 21st Floor  New York, New York 10004  As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, Mountain Crest Acquisition Corp. V, a Delaware corporation (“Company”), hereby confirms its agreement with Chardan Cap
November 9, 2021	EX-10.2	Form of Investment Management Trust Agreement by and between Continental Stock Transfer & Trust Company and the Registrant. Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made as of [?], 2021 by and between Mountain Crest Acquisition Corp. V (the ?Company?) and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, No. 333-260124 (?Registration Statement?), for its
November 9, 2021	EX-4.4	Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant. Exhibit 4.4 RIGHTS AGREEMENT This Rights Agreement (this “Agreement”) is made as of , 2021 between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State Street, New York, New York 10004 (the “Right Agent”). WHEREAS, the Company has received a firm commitment from Chardan Capital Ma
October 7, 2021	EX-3.1	Certificate of Incorporation. EX-3.1 3 mountaincrest5ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V THE UNDERSIGNED, in order to form a corporation for the purposes herein stated, under and pursuant to the provisions of the General Corporation Law of the State of Delaware, hereby certifies as follows: FIRST: The name of the corporation is Mountain Crest Acquisition Corp. V
October 7, 2021	EX-4.3	Specimen Right Certificate. Exhibit 4.3 NUMBER MCAGR RIGHTS MOUNTAIN CREST ACQUISITION CORP. V INCORPORATED UNDER THE LAWS OF THE DELAWARE RIGHT SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 62404B 115 THIS CERTIFIES THAT, for value received is the registered holder of a right or rights (each, a “Right”) to automatically receive one-tenth of one share of common stock, $0.0001 par value (“Common Stock”), of Mountain Crest Acquisi
October 7, 2021	EX-10.2	Form of Investment Management Trust Agreement by and between Continental Stock Transfer & Trust Company and the Registrant. Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made as of [●], 2021 by and between Mountain Crest Acquisition Corp. V (the “Company”) and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Form S-1, No. 333-[●] (“Registration Statement”), for its in
October 7, 2021	EX-4.1	Specimen Common Stock Certificate. Exhibit 4.1 NUMBER MCAGU UNITS MOUNTAIN CREST ACQUISITION CORP. V SEE?REVERSE?FOR CERTAIN DEFINITIONS CUSIP 62404B 206 UNITS CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE RIGHT TO RECEIVE ONE-TENTH OF ONE SHARE OF COMMON STOCK THIS CERTIFIES THAT is the owner of Units. Each Unit (?Unit?) consists of one (1) share of common stock, par value $0.0001 per share (?Common Stock?), of Mountain Crest Ac
October 7, 2021	EX-10.6	Administrative Services Agreement by and between the Registrant and Mountain Crest Global Holdings LLC. Exhibit 10.6 MOUNTAIN CREST ACQUISITION CORP. V 311 West 43rd Street, 12th Floor New York, NY 10036 [], 2021 Mountain Crest Global Holdings LLC 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the registration statement (the “Registration Statement”) for the initial publ
October 7, 2021	EX-10.3	Form of Stock Escrow Agreement among the Registrant, Continental Stock Transfer & Trust Company, and the Initial Stockholders. Exhibit 10.3 STOCK ESCROW AGREEMENT This STOCK ESCROW AGREEMENT, dated as of , 2021 (“Agreement”), by and among MOUNTAIN CREST ACQUISITION CORP. V, a Delaware corporation (“Company”), and the initial shareholders listed on the signature pages hereto (collectively, the “Initial Shareholders”) CONTINENTAL STOCK TRANSFER & TRUST COMPANY, a New York corporation (“Escrow Agent”). WHEREAS, the Company h
October 7, 2021	EX-10.4	Form of Registration Rights Agreement by and between the Registrant and Initial Stockholders. Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [●] day of [●], 2021, by and among Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”) and the undersigned parties listed under Investors on the signature page hereto (each, an “Investor” and collectively, the “Investors”). WHEREAS, the Investors and the
October 7, 2021	S-1	Power of Attorney (included on the signature page of the original filing hereof). As filed with the Securities and Exchange Commission on October 7, 2021 Registration No.
October 7, 2021	EX-14	Form of Code of Ethics. EX-14 18 mountaincrest5ex14.htm EXHIBIT 14 Exhibit 14 CODE OF ETHICS 1. Introduction The Board of Directors of Mountain Crest Acquisition Corp. V has adopted this code of ethics (this “Code”), which is applicable to all directors, officers and employees, to: ● promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and profess
October 7, 2021	EX-1.1	Form of Underwriting Agreement. Exhibit 1.1 5,000,000 Units Mountain Crest Acquisition Corp. V UNDERWRITING AGREEMENT , 2021 Chardan Capital Markets, LLC  17 State Street, 21st Floor  New York, New York 10004  As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, Mountain Crest Acquisition Corp. V, a Delaware corporation (“Company”), hereby confirms its agreement with Chardan Cap
October 7, 2021	EX-10.7	Form of Subscription Agreement between Registrant and Mountain Crest Global Holdings LLC. Exhibit 10.7 [?], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Ladies and Gentlemen: Mountain Crest Acquisition Corp. V (the ?Company?), a blank check company formed for the purpose of acquiring one or more businesses or entities (a ?Business Combination?), intends to register its securities under the Securities Act of 1933, as amended (?Securities Ac
October 7, 2021	EX-10.5	Form of Indemnity Agreement. EX-10.5 15 mountaincrest5ex10-5.htm EXHIBIT 10.5 Exhibit 10.5 FORM OF INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of , 2021, by and between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly held corporations as directors, officers or i
October 7, 2021	EX-4.4	Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant. EX-4.4 9 mountaincrest5ex4-4.htm EXHIBIT 4.4 Exhibit 4.4 RIGHTS AGREEMENT This Rights Agreement (this “Agreement”) is made as of , 2021 between Mountain Crest Acquisition Corp. V, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State Street, New York, New York 10004 (the “Right Agent”). WHEREAS, the Company has recei
October 7, 2021	EX-4.2	Specimen Common Stock Certificate. Exhibit 4.2 NUMBER MCAG   SHARES   MOUNTAIN CREST ACQUISITION CORP. V INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE COMMON STOCK       SEE REVERSE FOR CERTAIN DEFINITIONS This Certifies that   CUSIP 62404B 107 is the owner of       FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE COMMON STOCK OF   MOUNTAIN CREST ACQUISITION CORP. V   transferable on the books of
October 7, 2021	EX-10.1	Form of Insider Letter Agreement among the Registrant and the Registrant’s Officers and Directors. Exhibit 10.1 [?], 2021 Mountain Crest Acquisition Corp. V 311 West 43rd Street, 12th Floor New York, NY 10036 Chardan Capital Markets, LLC 17 State Street, Suite 1600 New York, NY 10004 Re: Initial Public Offering Gentlemen: This letter is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and between Mountain Crest Acquisition Corp.
October 7, 2021	EX-3.2	Form of Amended and Restated Certificate of Incorporation. Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V Pursuant to Sections 242 and 245 of the Delaware General Corporation Law Mountain Crest Acquisition Corp. V, a corporation existing under the laws of the State of Delaware (the “Corporation”), by its Chief Executive Officer, hereby certifies as follows: 1. The name of the Corporation is “Mountain Cr
October 7, 2021	EX-3.3	MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I EX-3.3 5 mountaincrest5ex3-3.htm EXHIBIT 3.3 Exhibit 3.3 BYLAWS OF MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - BY-LAWS OF MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I OFFICES SECTION 1. Principal Office. The registered office of the corporation shall be located in such place as may be provided from time to time in the Certificate of Incorporation. SECTION 2. Other Offices. The co
October 7, 2021	EX-99.2	Form of Compensation Committee Charter. Exhibit 99.2 COMPENSATION COMMITTEE CHARTER OF MOUNTAIN CREST ACQUISITION CORP. V Adopted: [], 2021 The responsibilities and powers of the Compensation Committee of the Board of Directors (the “Board”) of Mountain Crest Acquisition Corp. V (the “Company”), as delegated by the Board, are set forth in this charter (this “Charter”). Whenever the Compensation Committee takes an action, it shall exerci
October 7, 2021	EX-99.1	Form of Audit Committee Charter. Exhibit 99.1 AUDIT COMMITTEE CHARTER OF MOUNTAIN CREST ACQUISITION CORP. V Adopted: [], 2021 The responsibilities and powers of the Audit Committee of the Board of Directors (the ?Board?) of Mountain Crest Acquisition Corp. V (the ?Company?), as delegated by the Board, are set forth in this charter (this ?Charter?). Whenever the Audit Committee takes an action, it shall exercise its independent ju
September 9, 2021	EX-3.1	CERTIFICATE OF INCORPORATION MOUNTAIN CREST ACQUISITION CORP. V Exhibit 3.1 CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V THE UNDERSIGNED, in order to form a corporation for the purposes herein stated, under and pursuant to the provisions of the General Corporation Law of the State of Delaware, hereby certifies as follows: FIRST: The name of the corporation is Mountain Crest Acquisition Corp. V (hereinafter called the “Corporation”). SECON
September 9, 2021	DRS/A	Confidentially submitted to the Securities and Exchange Commission on September 8, 2021 This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confide Confidentially submitted to the Securities and Exchange Commission on September 8, 2021 This draft registration statement has not been publicly filed with the U.
September 9, 2021	EX-3.3	MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I EX-3.3 3 filename3.htm Exhibit 3.3 BYLAWS OF MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - BY-LAWS OF MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I OFFICES SECTION 1. Principal Office. The registered office of the corporation shall be located in such place as may be provided from time to time in the Certificate of Incorporation. SECTION 2. Other Offices. The corporation may also hav
June 14, 2021	DRS	Confidentially submitted to the Securities and Exchange Commission on June 11, 2021 This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidentia DRS 1 filename1.htm Confidentially submitted to the Securities and Exchange Commission on June 11, 2021 This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UN
June 14, 2021	EX-3.1	CERTIFICATE OF INCORPORATION MOUNTAIN CREST ACQUISITION CORP. V Exhibit 3.1 CERTIFICATE OF INCORPORATION OF MOUNTAIN CREST ACQUISITION CORP. V THE UNDERSIGNED, in order to form a corporation for the purposes herein stated, under and pursuant to the provisions of the General Corporation Law of the State of Delaware, hereby certifies as follows: FIRST: The name of the corporation is Mountain Crest Acquisition Corp. V (hereinafter called the “Corporation”). SECON
June 14, 2021	EX-3.3	MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I EX-3.3 3 filename3.htm Exhibit 3.3 BYLAWS OF MOUNTAIN CREST ACQUISITION CORP. V - A Delaware Corporation - BY-LAWS OF MOUNTAIN CREST ACQUISITION CORP. V ARTICLE I OFFICES SECTION 1. Principal Office. The registered office of the corporation shall be located in such place as may be provided from time to time in the Certificate of Incorporation. SECTION 2. Other Offices. The corporation may also hav

MCAG / Mountain Crest Acquisition Corp. V - SEC Filings, Annual Report, Proxy Statement

Basic Stats

SEC Filings

SEC Filings (Chronological Order)